- ►oxfordjournals.org B Bigalke, S Lindemann, R Ehlers, P Seizer, … - European heart journal, 2006 - Eur Soc Cardiology Methods and results We evaluated a consecutive cohort of 367 patients with
symptomatic CAD, who underwent coronary angiography. The surface expression of
platelet activation markers (GPVI, CD62P, and CD42b) was determined by flow ... Cited by 34 - Related articles - BL Direct - All 6 versions
JF Arthur, S Dunkley, RK Andrews - British Journal of Haematology, 2007 - interscience.wiley.com Human patients with defects associated with the platelet collagen receptor,
glycoprotein (GP)VI, are rare and usually described as having a mild bleeding
disorder. However, here we review clinical profiles of patients with ... Cited by 15 - Related articles - BL Direct - All 4 versions
- ►simi.it [PDF] F Santilli, S Basili, P Ferroni, G Davì - Internal and Emergency Medicine, 2007 - Springer CD40L is gaining much attention for its role in the initiation and progression
of atherosclerosis. Several distinct lines of investigation in the context of
atherosclerosis dealing with low-grade inflammation, oxidative stress and ... Cited by 13 - Related articles - BL Direct - All 3 versions
Y Yan, DR Phillips - Current Opinion in Pharmacology, 2005 - Elsevier Platelets are known to play a pivotal role not only in the formation of arterial
thrombosis but also in the progression of atherosclerotic disease. Recent data
suggest that these activities of platelets have become enhanced in patients ... Cited by 7 - Related articles - All 2 versions
C Grothusen, S Umbreen, I Konrad, K Stellos, … - Arteriosclerosis, thrombosis, and vascular biology, 2007 - Am Heart Assoc Methods and Results— EXP3179 and LOS but not EXP3174—the major AT 1
-receptor blocking metabolite of LOS—dose-dependently inhibited collagen-I
(P<0.01) and GPVI-dependent platelet aggregation (P<0.01) analyzed by ... Cited by 8 - Related articles - All 6 versions
KJ Clemetson, JM Clemetson - Current pharmaceutical design, 2007 - ingentaconnect.com Abstract: Platelets have important roles in atherosclerosis and thrombosis and
their inhibition reduces the risk of these disorders. There is still a need for
platelet inhibitors affecting pathways that reduce thrombosis and ... Cited by 6 - Related articles - BL Direct - All 3 versions
I Elalamy, T Chakroun, GT Gerotziafas, A … - Thrombosis Research, 2008 - Elsevier We have observed a significant increase of PPA and PMA levels in diabetics (22
± 12% and 45 ± 18%, respectively) compared to controls (7 ± 4% and 19 ± 10%,
respectively) (p < 0.01). However, both PPA and PMA values were similar in ... Cited by 6 - Related articles - All 10 versions
M Poggi, J Jager, O Paulmyer-Lacroix, F … - Diabetologia, 2009 - Springer Page 1. ARTICLE The inflammatory receptor CD40 is expressed on human adipocytes:
contribution to crosstalk between lymphocytes and adipocytes ... Cited by 4 - Related articles - All 2 versions
K Stellos, B Bigalke, H Langer, T Geisler, A … - European Heart Journal, 2008 - Eur Soc Cardiology Methods and results: Patients with ACS (n = 418) showed a significantly enhanced
SDF-1 expression on admission compared with those with stable angina pectoris
(SAP, n = 486) [SAP (mean fluorescence intensity (MFI)±SD): 13.48 ± 5.27; ... Cited by 4 - Related articles - All 4 versions
B Bigalke, T Geisler, K Stellos, H Langer, K … - American Heart Journal, 2008 - Elsevier Patients with ACS (n = 485) showed a significantly enhanced GPVI expression
compared to patients with stable angina pectoris (SAP; n = 518) (mean
fluorescence intensity for ACS 19.8 ± 5.9; SAP 18.7 ± 8.5, P = .01). ... Cited by 4 - Related articles - All 24 versions
